TP53 and neoplasm: Single-cell RNA sequencing data revealed an enrichment of FOLR2+ LYVE1+ macrophages in KRAS/TP53 double-mutant colon cancer, where tumor cells appear to engage in immunosuppressive crosstalk with macrophages via the CD24–Siglec-10 axis.